XML 90 R78.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Subsequent Events (Details) |  |  |  |  | 1 Months Ended | 3 Months Ended
--- | --- | --- | --- | --- | --- | ---
Jul. 08, 2024 USD ($) | Apr. 29, 2024 USD ($) employee milestone segment | Feb. 24, 2024 milestone | Dec. 01, 2021 USD ($) milestone | May 31, 2024 USD ($) | Feb. 29, 2024 USD ($) milestone | Mar. 31, 2024 milestone
Subsequent Event | Saudi Arabian Industrial Investments Company |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |
Payments to investment | $ |  |  |  |  | $ 2,450,000 |  |
Volumetric Biotechnologies, Inc. |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |
Milestones terminated |  |  | 4 |  |  | 4 | 4
Number of milestones |  |  |  | 7 |  |  |
Remaining milestones |  |  | 3 |  |  | 3 | 3
Additional payments | $ |  |  |  | $ 355,000,000 |  | $ 355,000,000 |
Volumetric Biotechnologies, Inc. | Subsequent Event |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |
Number of employees | employee |  | 2 |  |  |  |  |
Milestones terminated | segment |  | 4 |  |  |  |  |
Number of milestones |  | 7 |  |  |  |  |
Remaining milestones |  | 3 |  |  |  |  |
Additional payments | $ |  | $ 175,000,000 |  |  |  |  |
Litigation settlement, amount proposed to other party | $ | $ 1,500,000 |  |  |  |  |  |

X
- Definition Business Combination, Number Of Key Employees Required For Milestone + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfKeyEmployeesRequiredForMilestone
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number Of Milestones + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfMilestones
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number Of Milestones Terminated + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfMilestonesTerminated
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number Of Remaining Milestones + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfRemainingMilestones
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Litigation Settlement, Amount Proposed To Other Party + References No definition available. + Details
Name: | ddd_LitigationSettlementAmountProposedToOtherParty
Namespace Prefix: | ddd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ddd_SaudiArabianIndustrialInvestmentsCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ddd_VolumetricBiotechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |